SUNWAY(SZ:002469) Xin Lang Cai Jing·2025-09-25 01:28Core Viewpoint - The company, Sanwei Chemical, has shown positive financial performance with significant growth in revenue and net profit, alongside a stable shareholder structure and low financing levels [1][2][3]. Financial Performance - For the first half of 2025, Sanwei Chemical achieved a revenue of 1.249 billion yuan, representing a year-on-year growth of 21.81% [2]. - The net profit attributable to shareholders for the same period was 120 million yuan, reflecting a year-on-year increase of 42.54% [2]. Shareholder Structure - As of June 30, 2025, the number of shareholders for Sanwei Chemical was 42,500, a decrease of 17.75% compared to the previous period [2]. - The average number of circulating shares per shareholder increased by 21.58% to 14,790 shares [2]. Financing and Margin Trading - On September 24, 2023, Sanwei Chemical recorded a financing buy-in of 15.134 million yuan, with a net buy of 3.6306 million yuan [1]. - The total financing and margin trading balance stood at 226 million yuan, accounting for 3.93% of the circulating market value, which is below the 30% percentile level over the past year [1]. Dividend Distribution - Since its A-share listing, Sanwei Chemical has distributed a total of 1.291 billion yuan in dividends, with 681 million yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, the second-largest circulating shareholder is Hongli Low Volatility Dividend (512890), holding 27.8388 million shares, unchanged from the previous period [3]. - The sixth-largest shareholder, CCB Low Volatility Dividend Index A (005561), reduced its holdings by 170,600 shares to 7.7373 million shares [3].